SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes

By sjmartinez • January 13, 2025

Bhatti AW, Patel R, Dani SS, Khadke S, Makwana B, Lessey C, Shah J, Al-Husami Z, Yang EH, Thavendiranathan P, Neilan TG, Sadler D, Cheng RK, Dent SF, Liu J, Lopez-Fernandez T, Herrmann J, Scherrer-Crosbie M, Lenihan DJ, Hayek SS, Ky B, Deswal A, Barac A, Nohria A, Ganatra S. SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes. JACC CardioOncol. 2024 Sep 22;6(6):863-875. doi: 10.1016/j.jaccao.2024.08.001. PMID: 39801650; PMCID: PMC11711834.

Tags: antineoplastic therapy, Cardiology/Epi, cardiomyopathy, CTRCD, primary prevention, Publications, sodium glucose co-transporter 2 inhibitors

Related Posts

Intensive Versus Standard Blood Pressure Control After Endovascular Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials

Hashmi TM, Ahmed M, Ashraf H, Shakir M, Bhatti IA, Ahmed F, Alareed A, Hasan A, Ahmed R, Rafiq S, Aized MT, Fonarow GC, Hassan[...]

p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease

Salladay-Perez IA, Avila I, Estrada L, Alexandru AC, Ponce C, Dhingra A, Torres G, Deng CY, Hegde R, Gensheimer J, Kale A, Heckenbach I, Hui[...]

InChagas: Feasibility Study of a Tele-Education Strategy to Promote Early Identification and Care of People Living with Chagas Cardiomyopathy in an Endemic Community in Argentina

Gulayin PE, Gimenez C, Chirino D, Nascimento B, Salvá L, Cavallo AS, Gutierrez L, Blanco L, Flores LPC, Espina E, Shakil SS, Vervoort D, Davis[...]